 |
PDBsum entry 4ap7
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Discovery of a novel class of exquisitely selective mesenchymal-Epithelial transition factor (c-Met) protein kinase inhibitors and identification of the clinical candidate 2-(4-(1-(Quinolin-6-Ylmethyl)-1h-[1,2,3]triazolo[4,5-B]pyrazin-6-Yl)-1h-Pyrazol-1-Yl)ethanol (pf-04217903) for the treatment of cancer.
|
 |
|
Authors
|
 |
J.J.Cui,
M.Mctigue,
M.Nambu,
M.Tran-Dubé,
M.Pairish,
H.Shen,
L.Jia,
H.Cheng,
J.Hoffman,
P.Le,
M.Jalaie,
G.H.Goetz,
K.Ryan,
N.Grodsky,
Y.L.Deng,
M.Parker,
S.Timofeevski,
B.W.Murray,
S.Yamazaki,
S.Aguirre,
Q.Li,
H.Zou,
J.Christensen.
|
 |
|
Ref.
|
 |
J Med Chem, 2012,
55,
8091-8109.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
No abstract given.
|
 |
|
|
|
|
 |